packageTisotumabVedotin

tisotumab vedotin

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Tisotumab vedotin is an antibody-drug conjugate used to treat cervical cancer. It is authorised in the European Union and also remains under investigation for other uses.

Summary written by glm-5.3-flash from Wikidata Q108670929 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:tisotumab vedotin
ATC codes:L01FX23
DrugBank:DB16732
Wikidata:Q108670929
molar mass:153000 g/mol (Drugs.Common 25.09, not verified)

Metabolites

MonomethylAuristatinEmonomethyl auristatin E1250 g/mol (paper)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown

Contents

NameDescription
MonomethylAuristatinEmetabolite: monomethyl auristatin E